Tengion Inc. (TNGNQ)

[faraifarai]

Unclear still to me. Our patents? Seems that everything regenerative under wake defaults to us, or am I misreading?

[Wopsal101]

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60542-0/abstract

[Wopsal101]

This statement is from the undated prospectus. Hopefully someone on here knows better than me, however this appears to be our clinical partners and technology regarding the vagina paper in the Lancet. Am I wrong?


"As of March 15, 2014, we owned three issued U.S. patents and had licenses to 18 issued U.S. patents, 16 of which are exclusive and two of which are non-exclusive. We also have 19 U.S. patent applications and international Patent Cooperation Treaty (PCT) applications, and over 100 foreign patents and patent applications. The patent portfolio owned by us relates to the composition, design and methods of manufacture for our Neo-Urinary Conduit, Neo-Bladder Replacement and Neo-Bladder Augment product candidates, as well as technological advances associated with our Neo-Kidney Augment, Neo-Vessel Replacement, and Neo-GI Augment development programs. The licensed patent portfolio relates to technology developed by scientists and researchers associated with Children’s Medical Center Corporation and Wake Forest University Health Sciences. Also included within our portfolio are patents that address an array of regenerative medicine and tissue engineering technologies and product candidates outside the scope of our current product pipeline. "

[Wopsal101]

http://www.foxnews.com/health/2014/04/10/doctors-successfully-implant-lab-grown-vaginas-into-4-women/?intcmp=trending

[stonecoldG]

Nice move today, any ideas why or just was oversold??

[JUrology]

The fact remains the NKA animal studies were successful. Yes, funding is required to translate the IP to clinically proven products. HART has yet to delve into the FDA process as deep as Tengion has thus far. If Tengion's two candidate products work, subsequent products on the back burner will come out. As data is released, its success should become obvious. All or none for this MD. The market is impatient, which can lead to buying opportunities.

http://www.tengion.com/news/documents/Spencer-TERMIS-Presentation_121411_rev2.pdf

[faraifarai]

Listened to the Roth presentation and was reminded that celgene owns one-third of tengion. I didn't realize their stake was that big, but boosts confidence further. They have both investment and science driving them. They want this to succeed. The investing point is simple at .20.

[pepew]

Except the death...

[RevolRekop]

You can't be sure of nothing, because nothing is for sure my friend.

[faraifarai]

Sounds like a claim...

[Ecostate]

this is going to 10-15 cents... for sure

[scumbutt]

If your a Great One fan you must be a good guy

[Agent13]

Freelance gynecologist.

[JUrology]

Urologist.

[ridinbulls]

Please post often! Very nice info! Medical field?

[JUrology]

After reviewing available literature and studies done with Neo bladder augments for spina bifida patients, I believe this will translate well into a successful Neo urinary conduit. Assuming Tengion has figured out the tissue engineering, as they did before implanting children, the demands on an incontinent conduit are very much simplified. It appears the Neo Bladder Augment failed to be beneficial mainly due to lack of urodynamic improvement. As long as the Neo urinary conduit does not have increased rates of ureteral anastomotic strictures or stomal stenosis, I believe it will be a big deal. It sure would make robotic radical cystectomies more practical and drastically shortening hospital LOS.

The Neo kidney augment would be absolutely mind blowing. The benefit of this could be better than a whole new renal moiety for transplanting due to no need for vascular anastomosis or neoureterocystostomy. The details of how they are doing this in Sweden aren't clear, but exciting stuff.

[Ecostate]

.... just checkin in

[faraifarai]

Stick around for 3 years...

[Ecostate]

getting back in. shaping up...

[powboi]

Nice. Looks to be a consistent indicator in the past. Hopefully you're right. With 3 month period news coming out next week or the following on patient trials this could really see a big increase.

[RevolRekop]

18EMA about to cross 50EMA, watch what happened last time they crossed.

[Ecostate]

i sold already this this is just a stupid stock with stupid market makers. Pretty quickly everyone just leaves this one. this should just be shorted to nothing to screw whoever is in control. barf and goodbye

[hebercreeper]

it's the hedge funds with the interest payment shares dumping

[Ecostate]

turning into a piece of crap...get OFF THE FREAKIN ask idiots!!! Don't you know how to work it. This mm in control gets a big FAIL for not knowing how macd in the positive should be going up. !! People will just play elsewhere.... plenty out there. It goes up and buyers should come in. It stays here and no one comes in.

[hebercreeper]

MM's? I think you're above that one.

Ctrl-f "warrants"

Ctrl- f "convertible"

Ctrl-f "preferred"

Of course, the bullish outlook would be if all of the existing big name players want a follow on equal to existing ownership.

That said, the interest payment shares have been a killer.

[Ecostate]

Market makers at work here , pretty easy to see how they run things here. i AM loading with them

[Ecostate]

added a tad bit more here......

[powboi]

I don't have a link. The CEO said that they would release data at 3, 6, 9 and 12 month points. That's just what he said at the conference. I suppose he could be lying, but it didn't seem like it.

[ridinbulls]

Do you have a link for this?? According to the trial on clinical trials.gov they are not completing the trial until Sept of this year. I don't think they can release results before then...

http://www.clinicaltrials.gov/ct2/show/NCT01087697?term=Tengion&rank=8

[abbey1212]

I agree, looks like someone knows something. Second highest volume day of the year. Last high volume day the move was from .21 to .26 on March 5th. Of course we gave some of that back. Lets hope for the best.

[senderos]

I've seen that and it doesn't make any sense to me. They only have a few tens of millions out now, so 750M authorized should have been plenty.

[powboi]

Results on some patients are supposed to be released at the end of the month. Otherwise I don't know anything else.

[hondaboost]

TNGN, shares increased to 10 Billion from 750 M:

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9711718

[senderos]

This is trading like there is an important upcoming catalyst, but I don't know of one. Anyone?

[Ecostate]

Going to test 200 moving average here.

[senderos]

Maybe someone at the ROTH conference became a believer in the regenerative medicine tech of TNGN. Now, 50% of average daily volume in first 15 minutes.

[senderos]

What's going on this am with our little stock? 25% of normal daily volume already.

[ridinbulls]

Ok on the road right now but I will check it out this evening...Preciate it!

[senderos]

I can't remember a specific timeline, sorry. But you can get the PowerPoint slides from the website, I'm sure.

[ridinbulls]

Senderos...what was your take on the presentation? I have not had a chance to listen to it. Was there an update on the timeline for the bladder trial which should have data later in the year?

Thanks in advance!

[faraifarai]

It was presented late edt time, so buying I'm guessing today. Maybe volume slow wane in next 2 weeks unless pr..?

[senderos]

I listened to that live yesterday. That may be it.

[faraifarai]

Based on presentation now live on their website, my guess is new institutional buying in lead up to phase 2

[senderos]

Nice move here this am. Not sure why.

[faraifarai]

Curious if same presentation in previous public filing and/or market reaction this week. Dark horse is trial update or new trial, etc etc. should be interesting.

[senderos]

CEO to present at the ROTH conference tomorrow, Monday, March 10 at 3:30 Eastern. To access the webcast, go to:

http://wsw.com/webcast/roth28/TNGN

[faraifarai]

From Yahoo board:

Tengion Inc.’S Regenerative Medicine Could Save Lives And Revolutionize Health Care
03/07/2014 [ACCESSWIRE]
While regenerative medicine is at the cutting edge of bioscience and currently in its embryonic stages, if it someday works, it could save countless lives and completely revolutionize the health care system as we know it.
Tengion Inc.’s (OTCQB: TNGN) is one such company working on regenerative organ therapies
The Winston-Salem, N.C.-based company’s stock volume soared Mar. 6, with 1,520,841 shares changing hands, more than five times its three-month average volume of 287,725 shares. The uptick in volume could be triggered in part by anticipation of the company’s presentation at 26th Annual ROTH Conference on Monday, Mar. 10 at 12:30 p.m. PDT in Dana Point, CA. Rumors and speculation are rampant that the company will dazzle analysts with a presentation and some surprise announcements on the progress it is making. But, again, this is pure speculation.

More about Regenerative Medicine
Tengion is an interesting company because it is focused on developing its “Organ Regeneration Platform™” to harness what it says is the intrinsic regenerative pathways of the body to regenerate a range of native-like organs and tissues with the goal of delaying or eliminating the need for chronic disease therapies, organ transplantation, and the administration of anti-rejection medications.

The company is currently conducting Phase 1 clinical trials in Sweden and the U.S. for its Neo-Kidney Augment, which is intended to prevent or delay dialysis and transplantation by increasing renal function in patients with advanced chronic kidney disease. A Phase 1 trial for the Company's Neo-Urinary Conduit, an autologous implant that is intended to catalyze regeneration of native-like urinary tissue for bladder cancer patients requiring a urinary diversion following bladder removal, is ongoing. If such therapies can be developed and proven successful, it could mean keeping patients alive without organ transplants and saving literally billions of dollars in health care ex Less

[Lucky Moneysauce]

FWIW I'm out.

[uw86]

anyone please what is the fully-diluted outstanding shares for TNGN? the info on yahoo can't be accurate given the recent volume. thank you.

[Wopsal101]

Gas, I like the combination but I am thinking it is going to be GE.

http://www.nasdaq.com/article/ge-seeks-to-raise-3-billion-in-bonds-sale-20140306-00976